Cubist Systematic Strategies, LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$9,295
-32.1%
10,049
-20.0%
0.00%
Q1 2023$13,698
-58.5%
12,567
-44.5%
0.00%
Q4 2022$33,037
+725.9%
22,628
+980.6%
0.00%
Q2 2022$4,000
-95.6%
2,094
-95.3%
0.00%
-100.0%
Q1 2022$91,000
-69.9%
44,200
-45.1%
0.00%
-66.7%
Q4 2021$302,000
+0.7%
80,521
+38.9%
0.00%
-25.0%
Q3 2021$300,000
+614.3%
57,953
+485.4%
0.00%
Q2 2021$42,000
+90.9%
9,899
+135.7%
0.00%
Q1 2021$22,000
-81.2%
4,200
-80.6%
0.00%
-100.0%
Q4 2020$117,000
-40.9%
21,682
+9.8%
0.00%
-33.3%
Q2 2020$198,000
+125.0%
19,744
+29.6%
0.00%
-25.0%
Q4 2018$88,000
-44.7%
15,233
+29.7%
0.00%
-55.6%
Q3 2018$159,000
-34.0%
11,741
-42.3%
0.01%
-25.0%
Q2 2018$241,000
-5.1%
20,344
-10.0%
0.01%
-20.0%
Q1 2018$254,000
+96.9%
22,615
+16.8%
0.02%
+114.3%
Q4 2017$129,000
-29.1%
19,370
-12.6%
0.01%
-30.0%
Q3 2017$182,000
+2500.0%
22,169
+1747.4%
0.01%
Q1 2017$7,0001,200
+17042.9%
0.00%
Q4 2015$070.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 6,287,101$4,903,9392.63%
Syncona Portfolio Ltd 1,377,294$1,074,2891.60%
MPM BioImpact LLC 5,095,912$3,974,8111.06%
NEA Management Company, LLC 17,079,778$13,322,2271.03%
TANG CAPITAL MANAGEMENT LLC 5,166,954$4,030,2240.57%
PFM Health Sciences, LP 10,423,135$8,130,0450.38%
Matrix Capital Management Company, LP 38,974,185$30,399,8640.36%
Long Focus Capital Management, LLC 10,963,158$8,551,2630.31%
Acuitas Investments, LLC 479,764$374,2160.22%
Endurant Capital Management LP 311,944$243,3160.22%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders